This announcement is a separate document:
Anteris Technologies Ltd: Data Update on First-in-Human Study of DurAVR at NY Valves
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.